Scott Wapner and the Investment Committee discuss the chip rollover as many of the biggest names in the group continue to sell off. The experts detail their latest portfolio moves. The desk debates the very latest on the upcoming SpaceX IPO. Michael Santoli joins with his Midday Word. Oliver Renick highlights Options Action.
Investment Committee Disclosure ... Show More
Jun 4
Managing a Portfolio Full of Winners 6/4/26
Scott Wapner and the Investment Committee debate whether you should stick with the winners in the market or rotate out of these high-flying stocks. Plus, the desk share their latest portfolio moves. And later, we look ahead to the Space X IPO, Leslie Picker joins us with the late ... Show More
47m 5s
Jun 2024
Apple WWDC 2024, MoviePass Documentary
Bloomberg's Caroline Hyde discusses the latest from Apple as the company's annual developer conference kicks off in Cupertino, California. Plus, conversations with DreamWorks Founder Jeffrey Katzenberg and MoviePass Co-Founder Hamet Watt. See omnystudio.com/listener for privacy ... Show More
42m 36s
Sep 2024
Apple’s Strategy to Rule the World
Apple is at a turning point. It ascended from a scrappy tech underdog to the most valuable company in the world through selling devices like iPhones, Macs and Apple watches. But now, a significant portion of its revenue comes from digital services.
On today’s Big Take podcast, Bl ... Show More
13m 51s
Jun 2024
Apple and OpenAI make a deal
The Verge's Nilay Patel, Alex Cranz, and David Pierce discuss takeaways from WWDC, this week's gadget news, and Elon Musk dropping his lawsuit against OpenAI. Further reading: Apple and OpenAI aren’t paying each other yet, says Bloomberg MKBHD interviewed Tim Cook. Tim Cook is ‘n ... Show More
1h 37m
Sep 2025
Apple’s Device Delay… And Vaccine Makers Under Pressure 9/12/25
<p>Apple postponing the launch of its new iPhone Air model in China, as regulatory issues hit the tech giant. How they’ll clear that hurdle, and what a top tech analyst sees in store for the stock after a muted Apple event response. Plus A new report threatening vaccine makers, a ... Show More
44m 16s